| Sep 8 2023 |
FDA Issues Final Guidance on Informed Consent in Clinical Investigations |
McDermott Will & Schulte LLP |
| Sep 7 2023 |
France Reintroduces Bid to Ban Meat Names for Plant-Based Food |
Keller and Heckman LLP |
| Sep 7 2023 |
Context is Key: FDA Sends a Strong Message About Efficacy Claims |
Sheppard, Mullin, Richter & Hampton LLP |
| Sep 7 2023 |
EPA Posts Resources on Rule to Accelerate Use of PIPs |
Bergeson & Campbell, P.C. |
| Sep 6 2023 |
The Great Divide: The Feds’ Differing Approach to Psychedelics and Cannabis |
Bradley Arant Boult Cummings LLP |
| Sep 6 2023 |
Decentralized Clinical Trials: Sponsor Responsibilities |
Foley & Lardner LLP |
| Sep 5 2023 |
FDA Updates Seafood List Guidance |
Keller and Heckman LLP |
| Sep 5 2023 |
Unpacking Averages: How Accurate Do Class II Medical Devices Need to Be to Obtain 510(k) Clearance? |
Epstein Becker & Green, P.C. |
| Sep 5 2023 |
FDA Issues Final Guidance on Informed Consent for IRBs, Clinical Investigators, and Sponsors |
Epstein Becker & Green, P.C. |
| Sep 5 2023 |
State Regulation of Pharmacy Benefit Managers: Tenth Circuit Holds That ERISA and Medicare Part D Preempt Key Parts of Oklahoma PBM Law |
Epstein Becker & Green, P.C. |
| Sep 1 2023 |
CMS Names Its First Ten Negotiated Part D Drugs: Inflation Reduction Act Updates |
Epstein Becker & Green, P.C. |
| Sep 1 2023 |
Seventh Circuit Follows Illinois Supreme Court Precedent and Finds BIPA Claims Timely |
Vedder Price |
| Sep 1 2023 |
Reclassifying Cannabis as a Schedule III Substance – Will the DEA Agree? |
Sheppard, Mullin, Richter & Hampton LLP |
| Sep 1 2023 |
Kraft Heinz Agrees to Settle Suit Over Malic Acid Flavoring |
Keller and Heckman LLP |
| Sep 1 2023 |
Alabama Medical Cannabis Licensing Program Halted (Again): Is the Levee Goin’ to Break? |
Bradley Arant Boult Cummings LLP |
| Sep 1 2023 |
Medical Supplier Agrees to Pay $29 Million for FCA Violations |
ArentFox Schiff LLP |
| Aug 31 2023 |
Two New Drug Supply Chain Security Act Guidance to Help Pharmaceutical Supply Chain Partners Comply with the DSCSA’s Move to Electronic Tracking |
Nelson Mullins |
| Aug 31 2023 |
FDA Issues Warning Letters to Three Infant Formula Manufacturers |
Keller and Heckman LLP |
| Aug 31 2023 |
Does the End Justify the Means? Privacy Advocates React to the Cooper Davis Act |
Bradley Arant Boult Cummings LLP |
| Aug 31 2023 |
Smoke ‘Em if You Got ‘Em (OK, Not Just Yet): Feds Recommend Rescheduling Marijuana |
Bradley Arant Boult Cummings LLP |
| Aug 31 2023 |
No Two Ways About It: No Disparagement ≠ Teaching Away, Free Samples ≠ Commercial Success |
McDermott Will & Schulte LLP |
| Aug 31 2023 |
Alert: US DHHS Recommends Moving Cannabis to Schedule III |
Womble Bond Dickinson (US) LLP |
| Aug 31 2023 |
PFAS AFFF MDL Settlements Moving Forward |
CMBG3 Law |
| Aug 31 2023 |
Aspartame Safety Review by the WHO: a Short Story about a Tempest in a Teapot… |
Keller and Heckman LLP |
| Aug 30 2023 |
Demand Heats Up for Biochar Carbon Projects |
Beveridge & Diamond PC |
| Aug 30 2023 |
Largest U.S. E-Cigarette Clinical Trial Confirms Role in Smoking Cessation |
Keller and Heckman LLP |
| Aug 29 2023 |
FDA Signs Regulatory Partnership Arrangement with Ecuador Covering Shrimp Imports |
Keller and Heckman LLP |
| Aug 28 2023 |
Expert Testimony Rejected in California Heavy Metals Baby Food Lawsuit |
Keller and Heckman LLP |
| Aug 28 2023 |
TTB Issues Updated Guidance on Transfers of Beer Between Breweries Under Separate Ownership |
McDermott Will & Schulte LLP |
| Aug 25 2023 |
FDA’s Office of Prescription Drug Promotion Issues Second Untitled Letter of the Year to Exeltis for Misleading Statements Relating to SLYND® |
Sheppard, Mullin, Richter & Hampton LLP |
| Aug 25 2023 |
FDA Proposes to Amend Canned Tuna Standard |
Keller and Heckman LLP |
| Aug 25 2023 |
The Generative AI Revolution: Key Legal Considerations for the Cannabis Industry |
ArentFox Schiff LLP |
| Aug 24 2023 |
China Bans Seafood from Japan |
Keller and Heckman LLP |
| Aug 24 2023 |
How to Introduce Alternative Proteins via Tasting Trials in the Netherlands and Singapore |
Keller and Heckman LLP |
| Aug 24 2023 |
New York Cannabis Lawsuit Overview and Possible Effects on the Much-Anticipated Adult-Use Cannabis License Application Period |
Epstein Becker & Green, P.C. |
